Xconomy | San Diego - Business + Technology in the Exponential Economy

Related Posts

Biotech, VC, deals

Anaphore Gets Extra $13M

Juha-Pekka Tikka 5/14/09

San Diego-based Anaphore said today it has raised $13 million in a second closing of its Series A preferred stock financing, bringing the round to a total of $38 million. Anaphore, founded in 2008, is developing a new class of protein therapeutics for life-threatening diseases. The company’s investors are the SR One venture unit of GlaxoSmithKline, Merck Serono Ventures, Aravis, 5AM Ventures, Versant Ventures, and Apposite Capital.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.